Rare diseases
Investigational molecules
Locations
Back to Finland400 clinical trials in Helsinki, Finland across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FinlandKliinisetTutkimukset.fi(opens in a new tab)FinlandStudy on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
FinlandFinlandStudy of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function
FinlandStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
FinlandStudy on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation
FinlandStudy of Venetoclax and Azacitidine for Patients with Untreated Acute Myeloid Leukemia Who Cannot Have Standard Induction Therapy
FinlandStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
FinlandStudy Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature
FinlandStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
FinlandLong-Term Safety Study of Azacitidine for Patients with Blood Disorders Who Previously Participated in Azacitidine Clinical Trials
FinlandStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
FinlandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on vaccine development against various infectious diseases, including studies of RSV, meningococcal, and influenza vaccines in different age groups.
Research emphasizes safety, immunogenicity, and efficacy in diverse populations from infants to older adults.
Innovative research in stroke treatment and cerebral vasculature disorders, including studies on acute ischemic stroke interventions and vasoconstriction syndrome management.
Trials combine therapeutic interventions with lifestyle modifications to improve patient outcomes.
Studies addressing obesity management through novel therapeutic approaches combined with lifestyle interventions, focusing on weight-related complications.
Research emphasizes comprehensive treatment strategies for metabolic health improvement.
Advanced studies in acute myeloid leukemia treatment, investigating combination therapies for patients unsuitable for intensive chemotherapy.
Focusing on personalized treatment approaches for specific genetic mutations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
